Claudia Hanni Selected Research

apixaban

1/2020

Outcomes associated with apixaban vs warfarin in patients with renal dysfunction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Claudia Hanni Research Topics

Disease

2	Atrial Fibrillation 01/2020 - 06/2017
2	Hemorrhage 01/2020 - 06/2017
1	Thrombosis (Thrombus) 01/2020
1	Venous Thromboembolism 01/2020
1	Bacteremia 12/2019
1	Ischemic Stroke 05/2019
1	Critical Illness (Critically Ill) 05/2019
1	Stroke (Strokes) 05/2019
1	Hypertension (High Blood Pressure) 05/2019
1	Infections 05/2019

Drug/Important Bio-Agent (IBA)

1	apixabanIBA 01/2020
1	CreatinineIBA 01/2020
1	Warfarin (Coumadin)FDA LinkGeneric 01/2020
1	Vancomycin FDA LinkGeneric 12/2019
1	Anti-Infective Agents (Microbicides)IBA 12/2019
1	Nicardipine (Dagan)FDA LinkGeneric 05/2019
1	Labetalol (Normodyne)FDA LinkGeneric 05/2019
1	Heparin (Liquaemin)FDA LinkGeneric 06/2017

Therapy/Procedure

2	Length of Stay 12/2019 - 05/2019
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2020
1	Anticoagulation Bridge 06/2017